
Arcturus Therapeutics Holdings ARCT
€ 7.73
-4.14%
Quartalsbericht 2025-Q2
hinzugefügt 11.08.2025
Arcturus Therapeutics Holdings P/CF 2011-2025 | ARCT
P/CF Jährlich Arcturus Therapeutics Holdings
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -7.23 | -53.5 | 30.1 | -5.09 | -33 | -17.2 | -2.26 | -34.7 | -1.48 | -6.04 | -2.97 | -30.1 | -13 | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 30.1 | -53.5 | -13.6 |
P/CF anderer Aktien in der Pharmaeinzelhändler
| Name | P/CF | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Graybug Vision
GRAY
|
-0.0767 | $ 0.44 | -11.23 % | $ 9.65 M | ||
|
AgeX Therapeutics
AGE
|
-0.0018 | $ 11.3 | -10.17 % | $ 12.2 K | - | |
|
Galera Therapeutics
GRTX
|
-0.63 | $ 0.14 | -32.59 % | $ 7.61 M | ||
|
CureVac N.V.
CVAC
|
-4.82 | $ 5.32 | -0.47 % | $ 990 M | ||
|
AnPac Bio-Medical Science Co., Ltd.
ANPC
|
-3.04 | $ 4.37 | -1.58 % | $ 28.1 M | ||
|
Axon Enterprise
AXON
|
97.5 | $ 716.9 | -0.99 % | $ 54.3 B | ||
|
Caladrius Biosciences
CLBS
|
-0.185 | $ 0.43 | -16.75 % | $ 25.8 M | ||
|
Sorrento Therapeutics
SRNE
|
-2.09 | $ 0.27 | -29.58 % | $ 126 M | ||
|
BeiGene, Ltd.
BGNE
|
-1.8 K | $ 184.71 | 0.49 % | $ 251 B | ||
|
ContraFect Corporation
CFRX
|
-0.0235 | $ 1.47 | -5.16 % | $ 5.39 M | ||
|
Orchard Therapeutics plc
ORTX
|
-8.84 | $ 4.93 | 1.02 % | $ 90.8 M | ||
|
Midatech Pharma plc
MTP
|
-13.2 | $ 0.29 | -18.52 % | $ 27.3 M | ||
|
Advaxis
ADXS
|
-0.0633 | $ 0.31 | -9.65 % | $ 45.9 M | ||
|
Heat Biologics, Inc.
HTBX
|
-1.47 | $ 3.93 | -5.76 % | $ 99.8 M | ||
|
La Jolla Pharmaceutical Company
LJPC
|
3.89 | $ 6.2 | - | $ 154 M | ||
|
Zymeworks
ZYME
|
-4.39 | $ 6.42 | - | $ 404 M | ||
|
Aeterna Zentaris
AEZS
|
-4.82 | $ 5.72 | 5.93 % | $ 314 M | ||
|
Checkmate Pharmaceuticals
CMPI
|
-0.982 | $ 10.5 | - | $ 231 M | ||
|
Kadmon Holdings, Inc.
KDMN
|
-9.24 | $ 9.5 | - | $ 1.7 B | ||
|
Immatics N.V.
IMTX
|
-6.15 | $ 9.21 | -4.86 % | $ 579 M | ||
|
BioDelivery Sciences International
BDSI
|
7.5 | $ 2.58 | -4.8 % | $ 255 M | ||
|
Zosano Pharma Corporation
ZSAN
|
-1.91 | $ 0.56 | 7.23 % | $ 2.72 M | ||
|
Ayala Pharmaceuticals
AYLA
|
-0.224 | $ 0.5 | - | $ 7.46 M | ||
|
Krystal Biotech
KRYS
|
40.7 | $ 203.41 | 2.81 % | $ 5.82 B | ||
|
Lixte Biotechnology Holdings
LIXT
|
-1.03 | $ 4.17 | -5.87 % | $ 7.99 M | ||
|
Kiromic BioPharma
KRBP
|
-0.248 | $ 3.15 | 6.61 % | $ 3.08 M | ||
|
Acceleron Pharma Inc.
XLRN
|
-51.2 | $ 179.68 | - | $ 10.9 B | ||
|
Albireo Pharma
ALBO
|
-5 | $ 44.15 | -0.23 % | $ 916 M | ||
|
Stealth BioTherapeutics Corp
MITO
|
-10 | $ 0.32 | - | $ 23.9 M | ||
|
Trillium Therapeutics Inc.
TRIL
|
-48.4 | $ 18.44 | - | $ 1.94 B | ||
|
Kaleido Biosciences
KLDO
|
-0.956 | $ 0.29 | -3.69 % | $ 12.4 M | ||
|
Mesoblast Limited
MESO
|
-19.7 | $ 15.61 | -3.1 % | $ 10.1 B | ||
|
Entasis Therapeutics Holdings
ETTX
|
-1.71 | $ 2.19 | - | $ 105 M | ||
|
Humanigen
HGEN
|
-0.163 | $ 0.04 | -81.12 % | $ 4.28 M | ||
|
Aptinyx
APTX
|
-0.159 | $ 0.06 | -39.0 % | $ 4.57 M | ||
|
Tyme Technologies
TYME
|
-9.49 | $ 0.31 | 8.07 % | $ 54 M | ||
|
Forward Pharma A/S
FWP
|
-247 | $ 2.64 | -0.75 % | $ 18.7 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
-0.64 | $ 0.39 | - | $ 26.5 M | ||
|
Celyad Oncology SA
CYAD
|
-1.56 | $ 0.47 | - | $ 12.5 M | ||
|
Brickell Biotech
BBI
|
-2.62 | $ 2.11 | -5.38 % | $ 6.06 M | ||
|
Genocea Biosciences
GNCA
|
-1.6 | $ 0.05 | -15.0 % | $ 3.04 M | ||
|
Codiak BioSciences
CDAK
|
-3.23 | $ 0.06 | -55.98 % | $ 2.15 M | ||
|
Concert Pharmaceuticals
CNCE
|
-1.87 | $ 8.37 | - | $ 401 M | ||
|
AIkido Pharma
AIKI
|
-1.3 | $ 3.17 | 1.93 % | $ 17.4 M | ||
|
Calithera Biosciences
CALA
|
-14.5 | $ 0.37 | -10.95 % | $ 876 K | ||
|
Forma Therapeutics Holdings
FMTX
|
-3.12 | $ 20.01 | - | $ 958 M | ||
|
Arena Pharmaceuticals
ARNA
|
-12.5 | $ 49.55 | -6.81 % | $ 3.04 B | ||
|
Sierra Oncology
SRRA
|
-3.65 | $ 54.89 | -0.05 % | $ 1.34 B | ||
|
Regulus Therapeutics
RGLS
|
-1.97 | $ 8.16 | - | $ 155 M | ||
|
Институт стволовых клеток человека
ISKJ
|
-89 | - | - | - |